AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- The FDA on Friday approved datopotamab deruxtecan (Dato-DXd; Datroway) as a first-line option for unresectable or metastatic triple-negative breast cancer patients ineligible for immunotherapy. Approval of the Trop2-directed...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- Not long ago, I saw a patient whose disease was, by all clinical measures, under control. Her cystoscopy was clear. She was completing therapy as planned. There were no complications that would raise concern. At the end of...
(MedPage Today) -- The New York Times investigated the rapid expansion in autism therapy clinics in the U.S. with little regulatory oversight. Here are five takeaways from the report. Atomoxetine, metformin, isosorbide mononitrate, and levetiracetam...
(MedPage Today) -- Patients with obesity dropped a mean 28% of their body weight with a 12-mg dose of the investigational triple-receptor agonist retatrutide over 80 weeks in a phase III study, Eli Lilly announced. Nearly half had weight loss of...
(MedPage Today) -- Chronic hepatitis delta virus (HDV) infection has its first FDA-approved treatment, after the agency granted accelerated approval to bulevirtide (Hepcludex) injection for adults without cirrhosis or with compensated cirrhosis...
